MAPT and Alzheimer disease: The MAPT H1 haplotype, for example, has been found to be associated with increased risk in developing PSP [39], CBD [40], and AD (only in non-ApoE-4 carriers) [41], suggesting a common genetic link between tauopathies that contain 4-repeat scripts [42].